HAVCR2 and acute myeloid leukemia: With respect to the relation of TIM-3 expression with clinical outcomes of these AML patients, significantly different TIM-3 expression levels were not observed between patients who achieved CR or not after the induction chemotherapy (p=0.9799) (Figure 3D).